Home/Filings/4/0001209191-21-064473
4//SEC Filing

Hollander David 4

Accession 0001209191-21-064473

CIK 0001337553other

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 4:44 PM ET

Size

4.8 KB

Accession

0001209191-21-064473

Insider Transaction Report

Form 4
Period: 2021-11-11
Hollander David
Chief R&D Officer
Transactions
  • Tax Payment

    Common Stock

    2021-11-11$12.06/sh2,162$26,07431,676 total
Footnotes (1)
  • [F1]Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock.

Issuer

AERIE PHARMACEUTICALS INC

CIK 0001337553

Entity typeother

Related Parties

1
  • filerCIK 0001793796

Filing Metadata

Form type
4
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:44 PM ET
Size
4.8 KB